Atypical immature metaplasia (AIM) of the cervix: Is it related to high- grade squamous intraepithelial lesion (HSIL)

Li Geng, Denise C. Connolly, Christina Isacson, Brigitte Maria Ronnett, Kathleen R. Cho

Research output: Contribution to journalArticle

Abstract

Atypical immature metaplasia (AIM) is a poorly characterized cervical lesion with uncertain biological and clinical significance. AIM shares some, but not all, morphological features of squamous intraepithelial lesions (SILs). SILs are characterized by human papillomavirus (HPV) positivity and increased cellular proliferation, but these features have not been fully evaluated in AIM. Genomic DNA was extracted from 27 microdissected cervical biopsy specimens diagnosed as AIM. HPV DNA was detected by polymerase chain reaction (PCR), using two different sets of L1 gene consensus primers. HPV types were identified by sequence analysis of PCR products and comparison with published HPV sequences. The cell proliferation index was assessed by immunohistochemical staining for Ki-67 (MIB-1) antigen and expressed as the percentage of Ki-67-positive cells. Comparison groups included normal cervix (n = 10) and low-grade (LSILs, n = 19) and high-grade squamous intraepithelial lesions (HSILs, n = 11). Intermediate- or high-risk HPV DNA was detected in 67% (18 of 27) of AIM cases. Low-risk HPV DNA was not detected in any of the specimens. The Ki-67 index in AIM (mean, 33.0 ± 20.3; median, 29) was comparable to that of LSILs (mean, 21.4 ± 4.6; median, 21) and was significantly higher than that of normal cervix (mean, 11.0 ± 2.1; median, 11) (P <.01) and lower than that of HSILs (mean, 60.4 ± 13.2; median, 60) (P <.01). Of the cases with available follow-up, HPV-positive AIMs were significantly more likely to have a concurrent or subsequent diagnosis of typical HSIL (12 of 15, 80%) than HPV-negative AIMs (one of six, 45%) (P = .014). The wide range of Ki-67 indices and variable HPV status in AIM suggest that AIM represents a heterogeneous group of lesions including bona fide HSILs (high-risk HPV-positive, high Ki-67 index), antecedents (precursors?) of HSILs (high-risk HPV-positive, low to moderate Ki-67 index), and benign reactive conditions (HPV-negative, variable Ki-67 index). HPV testing may be useful in the assessment of atypical epithelial proliferations of the cervix for which a diagnosis of AIM is considered.

Original languageEnglish (US)
Pages (from-to)345-351
Number of pages7
JournalHuman Pathology
Volume30
Issue number3
StatePublished - Mar 1999
Externally publishedYes

Fingerprint

Metaplasia
Cervix Uteri
DNA
Squamous Intraepithelial Lesions of the Cervix
Cell Proliferation
Ki-67 Antigen
Polymerase Chain Reaction
Sequence Analysis

Keywords

  • Atypical immature metaplasia
  • Dysplasia
  • Human papillomavirus
  • Ki-67
  • Squamous intraepithelial lesion

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Atypical immature metaplasia (AIM) of the cervix : Is it related to high- grade squamous intraepithelial lesion (HSIL). / Geng, Li; Connolly, Denise C.; Isacson, Christina; Ronnett, Brigitte Maria; Cho, Kathleen R.

In: Human Pathology, Vol. 30, No. 3, 03.1999, p. 345-351.

Research output: Contribution to journalArticle

Geng, Li ; Connolly, Denise C. ; Isacson, Christina ; Ronnett, Brigitte Maria ; Cho, Kathleen R. / Atypical immature metaplasia (AIM) of the cervix : Is it related to high- grade squamous intraepithelial lesion (HSIL). In: Human Pathology. 1999 ; Vol. 30, No. 3. pp. 345-351.
@article{16ef0addf025425eb408aadc40db5272,
title = "Atypical immature metaplasia (AIM) of the cervix: Is it related to high- grade squamous intraepithelial lesion (HSIL)",
abstract = "Atypical immature metaplasia (AIM) is a poorly characterized cervical lesion with uncertain biological and clinical significance. AIM shares some, but not all, morphological features of squamous intraepithelial lesions (SILs). SILs are characterized by human papillomavirus (HPV) positivity and increased cellular proliferation, but these features have not been fully evaluated in AIM. Genomic DNA was extracted from 27 microdissected cervical biopsy specimens diagnosed as AIM. HPV DNA was detected by polymerase chain reaction (PCR), using two different sets of L1 gene consensus primers. HPV types were identified by sequence analysis of PCR products and comparison with published HPV sequences. The cell proliferation index was assessed by immunohistochemical staining for Ki-67 (MIB-1) antigen and expressed as the percentage of Ki-67-positive cells. Comparison groups included normal cervix (n = 10) and low-grade (LSILs, n = 19) and high-grade squamous intraepithelial lesions (HSILs, n = 11). Intermediate- or high-risk HPV DNA was detected in 67{\%} (18 of 27) of AIM cases. Low-risk HPV DNA was not detected in any of the specimens. The Ki-67 index in AIM (mean, 33.0 ± 20.3; median, 29) was comparable to that of LSILs (mean, 21.4 ± 4.6; median, 21) and was significantly higher than that of normal cervix (mean, 11.0 ± 2.1; median, 11) (P <.01) and lower than that of HSILs (mean, 60.4 ± 13.2; median, 60) (P <.01). Of the cases with available follow-up, HPV-positive AIMs were significantly more likely to have a concurrent or subsequent diagnosis of typical HSIL (12 of 15, 80{\%}) than HPV-negative AIMs (one of six, 45{\%}) (P = .014). The wide range of Ki-67 indices and variable HPV status in AIM suggest that AIM represents a heterogeneous group of lesions including bona fide HSILs (high-risk HPV-positive, high Ki-67 index), antecedents (precursors?) of HSILs (high-risk HPV-positive, low to moderate Ki-67 index), and benign reactive conditions (HPV-negative, variable Ki-67 index). HPV testing may be useful in the assessment of atypical epithelial proliferations of the cervix for which a diagnosis of AIM is considered.",
keywords = "Atypical immature metaplasia, Dysplasia, Human papillomavirus, Ki-67, Squamous intraepithelial lesion",
author = "Li Geng and Connolly, {Denise C.} and Christina Isacson and Ronnett, {Brigitte Maria} and Cho, {Kathleen R.}",
year = "1999",
month = "3",
language = "English (US)",
volume = "30",
pages = "345--351",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Atypical immature metaplasia (AIM) of the cervix

T2 - Is it related to high- grade squamous intraepithelial lesion (HSIL)

AU - Geng, Li

AU - Connolly, Denise C.

AU - Isacson, Christina

AU - Ronnett, Brigitte Maria

AU - Cho, Kathleen R.

PY - 1999/3

Y1 - 1999/3

N2 - Atypical immature metaplasia (AIM) is a poorly characterized cervical lesion with uncertain biological and clinical significance. AIM shares some, but not all, morphological features of squamous intraepithelial lesions (SILs). SILs are characterized by human papillomavirus (HPV) positivity and increased cellular proliferation, but these features have not been fully evaluated in AIM. Genomic DNA was extracted from 27 microdissected cervical biopsy specimens diagnosed as AIM. HPV DNA was detected by polymerase chain reaction (PCR), using two different sets of L1 gene consensus primers. HPV types were identified by sequence analysis of PCR products and comparison with published HPV sequences. The cell proliferation index was assessed by immunohistochemical staining for Ki-67 (MIB-1) antigen and expressed as the percentage of Ki-67-positive cells. Comparison groups included normal cervix (n = 10) and low-grade (LSILs, n = 19) and high-grade squamous intraepithelial lesions (HSILs, n = 11). Intermediate- or high-risk HPV DNA was detected in 67% (18 of 27) of AIM cases. Low-risk HPV DNA was not detected in any of the specimens. The Ki-67 index in AIM (mean, 33.0 ± 20.3; median, 29) was comparable to that of LSILs (mean, 21.4 ± 4.6; median, 21) and was significantly higher than that of normal cervix (mean, 11.0 ± 2.1; median, 11) (P <.01) and lower than that of HSILs (mean, 60.4 ± 13.2; median, 60) (P <.01). Of the cases with available follow-up, HPV-positive AIMs were significantly more likely to have a concurrent or subsequent diagnosis of typical HSIL (12 of 15, 80%) than HPV-negative AIMs (one of six, 45%) (P = .014). The wide range of Ki-67 indices and variable HPV status in AIM suggest that AIM represents a heterogeneous group of lesions including bona fide HSILs (high-risk HPV-positive, high Ki-67 index), antecedents (precursors?) of HSILs (high-risk HPV-positive, low to moderate Ki-67 index), and benign reactive conditions (HPV-negative, variable Ki-67 index). HPV testing may be useful in the assessment of atypical epithelial proliferations of the cervix for which a diagnosis of AIM is considered.

AB - Atypical immature metaplasia (AIM) is a poorly characterized cervical lesion with uncertain biological and clinical significance. AIM shares some, but not all, morphological features of squamous intraepithelial lesions (SILs). SILs are characterized by human papillomavirus (HPV) positivity and increased cellular proliferation, but these features have not been fully evaluated in AIM. Genomic DNA was extracted from 27 microdissected cervical biopsy specimens diagnosed as AIM. HPV DNA was detected by polymerase chain reaction (PCR), using two different sets of L1 gene consensus primers. HPV types were identified by sequence analysis of PCR products and comparison with published HPV sequences. The cell proliferation index was assessed by immunohistochemical staining for Ki-67 (MIB-1) antigen and expressed as the percentage of Ki-67-positive cells. Comparison groups included normal cervix (n = 10) and low-grade (LSILs, n = 19) and high-grade squamous intraepithelial lesions (HSILs, n = 11). Intermediate- or high-risk HPV DNA was detected in 67% (18 of 27) of AIM cases. Low-risk HPV DNA was not detected in any of the specimens. The Ki-67 index in AIM (mean, 33.0 ± 20.3; median, 29) was comparable to that of LSILs (mean, 21.4 ± 4.6; median, 21) and was significantly higher than that of normal cervix (mean, 11.0 ± 2.1; median, 11) (P <.01) and lower than that of HSILs (mean, 60.4 ± 13.2; median, 60) (P <.01). Of the cases with available follow-up, HPV-positive AIMs were significantly more likely to have a concurrent or subsequent diagnosis of typical HSIL (12 of 15, 80%) than HPV-negative AIMs (one of six, 45%) (P = .014). The wide range of Ki-67 indices and variable HPV status in AIM suggest that AIM represents a heterogeneous group of lesions including bona fide HSILs (high-risk HPV-positive, high Ki-67 index), antecedents (precursors?) of HSILs (high-risk HPV-positive, low to moderate Ki-67 index), and benign reactive conditions (HPV-negative, variable Ki-67 index). HPV testing may be useful in the assessment of atypical epithelial proliferations of the cervix for which a diagnosis of AIM is considered.

KW - Atypical immature metaplasia

KW - Dysplasia

KW - Human papillomavirus

KW - Ki-67

KW - Squamous intraepithelial lesion

UR - http://www.scopus.com/inward/record.url?scp=0033018699&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033018699&partnerID=8YFLogxK

M3 - Article

C2 - 10088555

AN - SCOPUS:0033018699

VL - 30

SP - 345

EP - 351

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 3

ER -